KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Total Non-Current Liabilities (2019 - 2025)

Adaptive Biotechnologies' Total Non-Current Liabilities history spans 6 years, with the latest figure at $287.7 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 14.59% year-over-year to $287.7 million; the TTM value through Dec 2025 reached $287.7 million, down 14.59%, while the annual FY2025 figure was $287.7 million, 14.59% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $287.7 million at Adaptive Biotechnologies, roughly flat from $286.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $343.4 million in Q2 2024 and bottomed at $240.4 million in Q2 2023.
  • The 4-year median for Total Non-Current Liabilities is $287.7 million (2025), against an average of $295.2 million.
  • The largest annual shift saw Total Non-Current Liabilities skyrocketed 42.85% in 2024 before it dropped 14.59% in 2025.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $267.2 million in 2022, then decreased by 10.01% to $240.4 million in 2023, then skyrocketed by 40.13% to $336.9 million in 2024, then fell by 14.59% to $287.7 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Total Non-Current Liabilities are $287.7 million (Q4 2025), $286.3 million (Q3 2025), and $317.1 million (Q2 2025).